Showing 3351-3360 of 8432 results for "".
Strategies for Success With Five Refractive IOLs
https://crstoday.com/topics/general/crst0209_09-php/41709/Differentiated Treatments for Dry Eye Disease (DED)
https://crstoday.com/crst-supplements/differentiated-treatments-for-dry-eye-disease-ded/differentiated-treatments-for-dry-eye-disease-ded/45419/Whether DED presents as evaporative, inflammatory, or both, physicians have a variety of tools in their treatment armamentarium.Efficiency at Every Stage
https://crstoday.com/crst-issues/april-2025/efficiency-at-every-stage/45478/Structured workflow enhance outcomes and reduce chair time.Accommodating IOLs
https://crstoday.com/topics/general/crst1009_03-php/41537/Separate or Together?
https://crstoday.com/crst-issues/2017-jul/separate-or-together/43479/Cross-linking and PRK: a sequential versus a combined strategy.The Hunt for Perfection
https://crstoday.com/topics/refractive-surgery/the-hunt-for-perfection/43674/Topography- and wavefront-guided approaches to refractive surgery each have strong points.Presbyopia Perspectives: A Global Discussion
https://crstoday.com/crst-issues/2022-aug/presbyopia-perspectives-a-global-discussion/44806/A virtual roundtable showcasing surgeons’ preferred treatments and patient selection for pharmacologic agents, premium IOL technologies, and refractive procedures.Secondary IOL Fixation
https://crstoday.com/crst-issues/may-2026/secondary-iol-fixation/60826/How we match the technique to the eye.Bridging the Presbyopia Gap
https://crstoday.com/crst-issues/feb-2026/bridging-the-presbyopia-gap/56574/The emerging role of topical pharmacologic therapy.Unlocking the Power of XDEMVY® in Treating Demodex Blepharitis
https://crstoday.com/crst-supplements/unlocking-the-power-of-xdemvy-in-treating-demodex-blepharitis/unlocking-the-power-of-xdemvy-in-treating-demodex-blepharitis/54512/Diagnosing Demodex blepharitis and examining pivotal SATURN data, and the ERSA and RHEA pilot studies.